Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Targeted Sequencing to Enhance, Liberate, and Optimize Treatment of Drug-resistant Tuberculosis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05553236
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:34.406868+00:00
Published At
2026-01-26T00:00:00+00:00
Record Updated At
2026-01-26
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Drug-resistant Tuberculosis", "HIV Coinfection", "Cost-Benefit Analysis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-01-26"
protocolSection.identificationModule.nctId
"NCT05553236"
protocolSection.identificationModule.officialTitle
"Targeted Sequencing to Enhance, Liberate, and Optimize Treatment of Drug-resistant Tuberculosis"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Drug-resistant Tuberculosis (protocolSection.conditionsModule.conditions)
  • HIV Coinfection (protocolSection.conditionsModule.conditions)
  • Cost-Benefit Analysis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.